CoChat

Chemopreventive Strategies Using NSAIDs and COX-2 Inhibitors

Open access
Keller, Josbert, Giardello, Francis · 2003 · Cancer Biology & Therapy
Cited by 117

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The chemopreventive efficacy of NSAIDs against colorectal cancer has been established. Also, NSAIDs may decrease the incidence of carcinomas of the esophagus, stomach, breast, lung, prostate, urinary bladder and ovary. The clinical use of these agents is limited to patients with familial adenomatous polyposis (FAP), which may benefit from chemopreventive treatment with sulindac or the selective COX-2 inhibitor celecoxib. The mechanism of chemoprevention by NSDAIDs is still a matter of debate. COX-2 inhibition explains at least part of the observed effects, however, other targets have been proposed. The effect of NSAIDs is incomplete and molecular mechanisms related to resistance need to be studied. Also, more effective chemopreventive regimens are needed; combination therapy appears attractive, potentially increasing efficacy and decreasing toxicity. This review discusses molecular and clinical aspects of chemoprevention of the adenomacarcinoma sequence with NSAIDs or COX-2 inhibitors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4161/cbt.214

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 117

Metadata

Authors
Keller, J., & Giardello, F.
Venue
Cancer Biology & Therapy
Published
2003-03
Volume
2
Issue
sup1
Pages
139-148
ISSN
  • 1538-4047 (ISSN-L)
  • 1555-8576
OpenAlex
W2015959127
Cited by
117
References
2
FWCI
6.98
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.